Inspire Medical Systems, Inc. (INSP) stock
INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3057% below fair value
$59.41+0.29 (+0.49%)
Close on Nov 17, 2026Market cap $1.72BP/E 12.9Yield –
Inspire Medical Systems operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Inspire Medical Systems's operating cash flow for the twelve months ending Jun 30, 2026 was $157.07M, up 33.7% year over year. For fiscal 2025 it was $116.98M, down 10.2% from the year before. The highest annual figure on record is $130.25M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $116.98M | -10.2% |
| FY2024 | Dec 31, 2024 | $130.25M | +428.3% |
| FY2023 | Dec 31, 2023 | $24.65M | +113.1% |
| FY2022 | Dec 31, 2022 | $11.57M | – |
| FY2021 | Dec 31, 2021 | -$20.12M | – |
| FY2020 | Dec 31, 2020 | -$53.05M | – |
| FY2019 | Dec 31, 2019 | -$32.85M | – |
| FY2018 | Dec 31, 2018 | -$18.69M | – |
| FY2017 | Dec 31, 2017 | -$15.79M | – |
| FY2016 | Dec 31, 2016 | -$17.95M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $23.23M | +765.4% |
| Q1 FY2026 | Mar 31, 2026 | $12.85M | – |
| Q4 FY2025 | Dec 31, 2025 | $52.47M | -24.2% |
| Q3 FY2025 | Sep 30, 2025 | $68.53M | +31.1% |
| Q2 FY2025 | Jun 30, 2025 | $2.68M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.70M | -175.7% |
| Q4 FY2024 | Dec 31, 2024 | $69.18M | +300.7% |
| Q3 FY2024 | Sep 30, 2024 | $52.28M | +1337.1% |
| Q2 FY2024 | Jun 30, 2024 | -$78.00K | -101.5% |
| Q1 FY2024 | Mar 31, 2024 | $8.86M | – |
| Q4 FY2023 | Dec 31, 2023 | $17.27M | -10.4% |
| Q3 FY2023 | Sep 30, 2023 | $3.64M | -66.9% |
| Q2 FY2023 | Jun 30, 2023 | $5.09M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.34M | – |
| Q4 FY2022 | Dec 31, 2022 | $19.27M | +2525.2% |
| Q3 FY2022 | Sep 30, 2022 | $11.00M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.95M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.75M | – |
| Q4 FY2021 | Dec 31, 2021 | $734.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$338.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$10.11M | – |
| Q1 FY2021 | Mar 31, 2021 | -$10.40M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.11M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.91M | – |
| Q2 FY2020 | Jun 30, 2020 | -$25.25M | – |
| Q1 FY2020 | Mar 31, 2020 | -$14.78M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.08M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.94M | – |
| Q2 FY2019 | Jun 30, 2019 | -$12.88M | – |
| Q1 FY2019 | Mar 31, 2019 | -$10.94M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.59M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.55M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.13M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.42M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.28M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.13M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.03M | – |
| Q1 FY2017 | Mar 31, 2017 | -$5.36M | – |
See a number that looks wrong?